Relationship between RNA synthesis, cell division, and morphology of mammalian cells. I. Puromycin aminonucleoside as an inhibitor of RNA synthesis and division in HeLa cells.
Logarithmically growing HeLa cell monolayers were treated with a range of concentrations of puromycin aminonucleoside (AMS). The effects of AMS were studied by the following means: microscope examination of treated cells; enumeration of the cell number using an electronic particle counter; analyses for DNA, RNA, and protein content; incorporation of P(32) and H(3)-thymidine into nucleic acids; and fractionation of nucleic acids by column chromatography. Taking the rate of incorporation of the isotopic precursor as a measure of nucleic acid synthesis, it was found that concentrations of the inhibitor which had a rapid effect on the rate of cell division inhibited the synthesis of all types of nucleic acids and of protein, but depressed ribosomal RNA synthesis most markedly. Lower concentrations of AMS selectively inhibited ribosomal RNA and, to a lesser extent, transfer RNA synthesis. Partial inhibition of ribosomal RNA synthesis with low doses had no effect on the rate of cell division within the period studied (3 generation times). The cell content of RNA returned to normal when the inhibitor was removed.
D002455:Cell Division / Q000187:drug effects*; D002852:Chromatography, Ion Exchange; D046508:Culture Techniques; D004273:DNA, Neoplasm / Q000096:biosynthesis*; D006367:HeLa Cells; D006801:Humans; D009363:Neoplasm Proteins; D009705:Nucleosides / Q000494:pharmacology*; D010759:Phosphorus Isotopes; D011691:Puromycin / Q000494:pharmacology*; D012334:RNA, Neoplasm / Q000096:biosynthesis*; D013936:Thymidine / Q000378:metabolism; D014316:Tritium
D004273:DNA, Neoplasm; D009363:Neoplasm Proteins; D009705:Nucleosides; D010759:Phosphorus Isotopes; D012334:RNA, Neoplasm; D014316:Tritium; D011691:Puromycin; D013936:Thymidine